DTM™ spinal cord stimulation shows superior back pain relief in RCT
By Akshay Kedari  Date: 2020-01-22

DTM™ spinal cord stimulation shows superior back pain relief in RCT

Medtronic plc, a Dublin-based medical technology, services, and solutions company, has reportedly announced three-month results from a large, multicenter RCT (randomized controlled trial) demonstrating statistically meaningful (p=0.0009) and improved back pain relief with DTM (Differential Target Multiplexed) SCS (Spinal Cord Stimulation) compared to conventional SCS. Both arms have used the company’s Intellis™ platform.

Reportedly, the three-month outcomes demonstrated 80% of chronic back pain patients treated with DTM registered minimum 50% pain relief, compared to 51% of the patients treated with conventional SCS, as measured by VAS (Visual Analog Scale).

Meanwhile, the RCT showed great pain relief and substantial reductions in leg and back pain with DTM. 63% of patients with back pain treated with DTM showed great pain relief of 80% or more compared to 26% treated with conventional SCS.

All in all, patients treated with DTM demonstrated an average of 74% decrease in back pain compared to 46% with conventional SCS for three months period. Likewise, improvements were noted with DTM for leg pain with a mean decrease of 72% compared to 59% with conventional SCS.

Matt Thomas, General Manager and Vice President of the Stim and Early Interventions business, that is part of the Restorative Therapies Group at Medtronic, said that DTM therapy is the first customized SCS approach purposely created from new scientific concept and demonstrated in an RCT.

The clinical study determines that DTM therapy offers greater efficacy for chronic back pain patients compared to conventional stimulation. Moreover, when combined with Medtronic Intellis, patients could access superior results as displayed in the RCT on an unrivaled simulation platform.

For a record, Medtronic secured DTM therapy as part of its acquisition of Stimgenics declared in early January. DTM therapy is a new and unique programming option to treat patients who are suffering from chronic pain, and is based on years of preclinical research.

Source Credit - http://newsroom.medtronic.com/news-releases/news-release-details/dtmtm-spinal-cord-stimulation-using-medtronic-intellistm

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...

NASA completes construction of ‘LC-48’ at Kennedy Space Center
NASA completes construction of ‘LC-48’ at Kennedy Space Center
By Akshay Kedari

The National Aeronautics and Space Administration (NASA) has reportedly announced the completion of the construction of its new launchpad at the Kennedy Space Center based in Florida. Notably, the new Launch Complex 48 or LC-48 is a pad that will be ...

How are energy storage applications driving conductive polymers demand?
How are energy storage applications driving conductive polymers demand?
By Akshay Kedari

With viable environmental stability and mechanical upsides, conductive polymers market players are gearing to infuse funds in the sector. Considered as the 4th generation of polymeric materials, one of the major selling points of conductive polymers ...